Macquarie Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Macquarie Group’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-75,000	Closed	-$1.42M	–	1997
2019 Q3	$1.42M	Hold	75,000	–	–	﹤0.01%	1117
2019 Q2	$883K	Hold	75,000	–	–	﹤0.01%	1246
2019 Q1	$1.02M	Hold	75,000	–	–	﹤0.01%	1181
2018 Q4	$769K	Hold	75,000	–	–	﹤0.01%	1223
2018 Q3	$1.25M	Hold	75,000	–	–	﹤0.01%	1150
2018 Q2	$1.19M	Hold	75,000	–	–	﹤0.01%	1136
2018 Q1	$953K	Sell	75,000 -900	-1%	-$13K	﹤0.01%	1194
2017 Q4	$869K	Buy	75,900 +900	+1%	+$10K	﹤0.01%	1277
2017 Q3	$919K	Hold	75,000	–	–	﹤0.01%	1236
2017 Q2	$859K	Sell	75,000 -127,613	-63%	-$2.36M	﹤0.01%	1209
2017 Q1	$4.21M	Buy	202,613 +62,124	+44%	+$1.38M	0.01%	791
2016 Q4	$2.92M	Buy	140,489 +40,000	+40%	+$1.04M	0.01%	865
2016 Q3	$3.29M	Sell	100,489 -100,411	-50%	-$3.06M	0.01%	830
2016 Q2	$5.02M	Buy	200,900 +130,900	+187%	+$3.54M	﹤0.01%	873
2016 Q1	$1.71M	Buy	+70,000	New	+$1.62M	﹤0.01%	1000

Macquarie Group's ALDR Position: Q4 2019 in Review

Macquarie Group sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 75,000 shares — an estimated $1.42M sold.

Macquarie Group first reported a position in ALDR in Q1 2016 and held it in 15 quarters. The position peaked at $5.02M in Q2 2016. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Macquarie Group reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Macquarie Group sold 75,000 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1.42M.
Macquarie Group first reported a position in Alder Biopharmaceuticals in Q1 2016 and held it in 15 quarters.
Macquarie Group's Alder Biopharmaceuticals position peaked at $5.02M in Q2 2016.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Macquarie Group's 13F filing for Q4 2019, filed 14 Feb 2020.